We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD,discusses data from The Liver Meeting on treatment of hepatitis C virus infection among individuals with hepatocellular carcinoma.
“Why this study is important is because many years ago there was some controversy regarding when you have someone with liver cancer, whether you should treat their hep C,” Terrault, professor of medicine, chief of gastroenterology and liver diseases, and Neil Kaplowitz Endowed Chair in Liver Diseases Research at the University of Southern California Keck School of Medicine, told Healio.
“There were some earlier studies that suggested that if you treated their hepatitis C that it might potentially make their liver cancer worse. That idea has now been solidly debunked, so we now know that’s not true,” Terrault continued. “But there still may be some residual reluctance to treat patients because of that early suggestion that there may be some negative consequences of treating the hepatitis C.”
